Sign In

Antony Cooper

Assoc Professor at Garvan Institute of Medical Research

Associate Professor Antony Cooper is a prominent researcher at the Garvan Institute of Medical Research in Sydney, Australia, specializing in neurodegenerative diseases, particularly Parkinson's disease.13 He serves as the Head of both the Neurodegeneration & Neurogenomics Program and the Neuroscience Division at the institute.1

Cooper's research focuses on:

  1. Identifying the underlying mechanisms of Parkinson's disease
  2. Developing neuroprotective therapies to slow or stop disease progression
  3. Using neurogenomic approaches to find peripheral biomarkers for early diagnosis and treatment efficacy assessment
  4. Investigating the genetic basis of bipolar disorder through whole genome sequencing and transcriptional analysis13

As a cell and molecular biologist/geneticist, Cooper completed his PhD at McGill University and conducted postdoctoral studies at the University of Oregon.3 He has held positions as an Assistant Professor at the University of Missouri and is currently a tenured Associate Professor at the Garvan Institute.3

Cooper also serves as the Research Director of the Australian Parkinson's Mission (APM), further emphasizing his commitment to advancing Parkinson's disease research.2 His work is crucial in the quest to understand and potentially cure this debilitating neurodegenerative disorder.

Highlights

Aug 9 · unsw.edu.au
Dr Antony Cooper - UNSW Sydney
Apr 9 · nhmrc.gov.au
Working to stop Parkinson's disease - NHMRC

Related Questions

What are the main goals of the Australian Parkinson's Mission?
How does Antony Cooper's research contribute to understanding Parkinson's disease?
What specific neurogenomic approaches does Antony Cooper use in his research?
Can you explain the significance of peripheral biomarkers in Parkinson's disease?
What are some of the recent publications by Antony Cooper?
A
Add to my network

Location

Greater Sydney Area